SC
RDY icon

Seldon Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Seldon Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,950
Closed -$71.9K – 206
2022
Q4 		$71.9K Hold
6,950
– – 0.06% 106
2022
Q3 		$73K Hold
6,950
– – 0.05% 102
2022
Q2 		$77K Hold
6,950
– – 0.04% 106
2022
Q1 		$77K Hold
6,950
– – 0.05% 125
2021
Q4 		$91K Buy
+6,950
New +$87.6K 0.06% 114

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Seldon Capital's RDY Position: Q1 2023 in Review

Seldon Capital sold out of Dr. Reddy's Laboratories (RDY) in Q1 2023, closing a stake of 6,950 shares — an estimated $71.9K sold.

Seldon Capital first reported a position in RDY in Q4 2021 and held it in 5 quarters. The position peaked at $91K in Q4 2021. 190 funds tracked by Wall St. Rank hold RDY as of Q1 2023.

  • Seldon Capital reported no remaining Dr. Reddy's Laboratories position as of Q1 2023 after selling out during the quarter.
  • Seldon Capital sold 6,950 Dr. Reddy's Laboratories shares in Q1 2023, an estimated $71.9K.
  • Seldon Capital first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 5 quarters.
  • Seldon Capital's Dr. Reddy's Laboratories position peaked at $91K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.